Changes of diffusing capacity after neoadjuvant concurrent chemoradiotherapy: implication on postoperative pulmonary complications in non-small cell lung cancer patients

s. shin (seoul, Republic of Korea), Y. Choi (seoul, Republic of Korea), J. Jung (seoul, Republic of Korea), Y. Im (seoul, Republic of Korea), H. Park (seoul, Republic of Korea), J. Cho (seoul, Republic of Korea), H. Kim (seoul, Republic of Korea), J. Kim (seoul, Republic of Korea), J. Zo (seoul, Republic of Korea), Y. Shim (seoul, Republic of Korea), H. Lee (seoul, Republic of Korea), H. Park (seoul, Republic of Korea)

Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2225
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
s. shin (seoul, Republic of Korea), Y. Choi (seoul, Republic of Korea), J. Jung (seoul, Republic of Korea), Y. Im (seoul, Republic of Korea), H. Park (seoul, Republic of Korea), J. Cho (seoul, Republic of Korea), H. Kim (seoul, Republic of Korea), J. Kim (seoul, Republic of Korea), J. Zo (seoul, Republic of Korea), Y. Shim (seoul, Republic of Korea), H. Lee (seoul, Republic of Korea), H. Park (seoul, Republic of Korea). Changes of diffusing capacity after neoadjuvant concurrent chemoradiotherapy: implication on postoperative pulmonary complications in non-small cell lung cancer patients. 2225

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Survival and postoperative complication after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer: a balancing exercise
Source: Eur Respir J 2003; 22: Suppl. 45, 31s
Year: 2003

Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011


Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy
Source: Eur Respir Rev 2013; 22: 565-576
Year: 2013



Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 771s
Year: 2006

Impact of neoadjuvant therapies on surgical indications and early postoperative outcome
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Initial combined intratumoral chemotherapy with cisplatin and irradiation for inoperable non-small cell obstructive lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 492s
Year: 2004

Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Weekly administration of gemcitabine in outpatient clinic for the patients with recurrent non-small cell lung cancer after pulmonary resection
Source: Eur Respir J 2006; 28: Suppl. 50, 781s
Year: 2006

Long-term follow-up comparing postoperative chemotherapy or radiotherapy and surgery with surgery alone in resectable nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 131s
Year: 2001

Correlation between parameters of quality of life in patients with non-small cell lung cancer treated by chemotherapy and radiotherapy
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Lung function evaluation in gemcitabine and concurrent radiotherapy treatment in nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 376s
Year: 2001

The 7-year results of the surgical treatment of non-small cell lung cancer (NSCLC) patients and the influence of neoadjuvant treatment
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007


Role of chemotherapy in stage III non-small cell lung cancer (NSCLC): adjuvant or induction?
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 478s
Year: 2004

Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 752s
Year: 2006

Comparison of quality of life in patients with non-small cell lung cancer treated by chemotherapy or radiotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004

Is there any place for perioperative radiation therapy?
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Survival of elderly patients with non-small lung cancer tretaed with combined chemotherapy and radiotherapy
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Combination of neoadjuvant and adjuvant chemotherapy in marginally resectable IIIA nonsmall cell lung cancer (NSCLC): long-term follow up
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006